The Phase 1 trial was a randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single and multiple ...

History or current diagnosis of significant ECG abnormalities * Resting QTcF ≥450 msec (male) or ≥460 msec (female) at pre-treatment as per central ECG reading at screening visit * Use of other ...

Expert Rev Neurother. 2010;10(7):1053-1088.

1 Department of Radiation Oncology, Xi'an Chest Hospital Affiliated to Northwest University, Xi'an, China 2 Department of Cardiovascular Medicine, Xi'an Chest Hospital Affiliated to Northwest ...

An Open Label, Multi-center Asciminib Roll-over Study to Assess Long-term Safety in Patients Who Have Completed a Novartis Sponsored Asciminib Study and Are Judged by the Investigator to Benefit From ...